Alivus Lifesciences - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Willow Lane Acquisition enters public markets with $10 per unit IPO, betting on selective dealmaking

Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures

Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms

Why Eli Lilly and Company is stockpiling a weight loss pill before the FDA has even said yes

Read More

4 minute read

Technology Industry News

Dev Information Technology (NSE: DEVIT) bags order from Alivus Lifesciences for Microsoft and Zoho licenses

Dev IT wins ₹4.4 Cr order from Alivus Lifesciences, strengthening its enterprise software and pharma-sector footprint. Read how this deal supports its FY26 momentum.

byPallavi Madhiraju

July 3, 2025

web analytics